Skip to main content
University of Michigan Innovation Partnerships
University of Michigan Innovation Partnerships

Portfolio

NyNex

Small molecule deubiquitinase inhibitors (DUBs) for cancer treatment.
(2017)

Freezer Nanny

Initially developed in Molecular & Behavioral Neuroscience Institute, University of Michigan, deployed in MBNI starting in 2013, monitoring 78 freezers, room temperature, light and humidity across University of Michigan and Wayne State University.
(2016)

Iris Messaging

A system to provide modern hospitals with a modern communications solution.
(2016)

MedigenixBio

MDI Therapeutics has assembled a management team with a combination of drug development, manufacturing and basic research expertise in serpin biology.
(2016)

Melius Outcomes

Our new web-based, quality improvement software platform uses your existing EHR clinical data to dramatically improve patient outcomes by providing exactly what your staff needs to find and fix the issue.

(2016)

MoxyTech

MoxyTech designs a mobile app to track pain with 3D modeling.  GeoPain, is a clinically proven software solution for tracking, analyzing, and communicating the details lost with existing pain assessment methods. An intuitive interface allows patients to quickly “paint” their pain on a 3D model, while researchers and clinicians aggregate and analyze the data locally or across populations.
(2016)

Resonant Therapeutics

Developer of novel therapeutics designed to treat cancer.
(2016)

ViewPoint Therapeutics

Biotechnology company dedicated to the development of treatments for diseases of protein misfolding, including cataracts.
(2016)

Argessin

GPCR inhibitors for Parkinson's disease and chronic pain
(2015)

Confo Therapeutics

Drug discovery platform using novel antibody fragments
(2015)

FlexDex Surgical

Laparoscopy tool that provides surgeons with greater dexterity and natural motion when sewing sutures
(2015)

Ivogen

Novel therapeutic approach to treat pathogenic bacteria.
(2015)

Kura Oncology

Precision medicine for cancer
(2015)

Medsyn Biopharma LLC

Therapeutics for cancer
(2015)

Opsidio, LLC

Therapeutic monoclonal antibody for pulmonary fibrosis/asthma/fibrotic lung disease
(2015)

PFS Genomics

Personalized treatment methodologies for breast cancer
(2015)

Rapid Oxygen Company

Portable emergency oxygen delivery system
(2015)

ONL Therapeutics

FAS apoptosis inhibitors to protect photoreceptors and preserve patient vision from retinal diseases.  ONL is focused on preventing the death of key retinal cells, including photoreceptors—the root cause of vision loss and the leading cause of blindness.
(2014)
1 3 4 5 6 7 8 9 12